GMAB

Q: What is the price of Genmab (GMAB) today?

The price of Genmab (GMAB) today is US$ 31,81, with a variation of 34.16% compared to the last year. The price of Genmab (GMAB) started the year trading around US$ 20,87 and today it is at US$ 31,81. Follow the real-time price chart, the historical price of Genmab (GMAB), and stock data from Ibovespa and international markets.

Q: When does Genmab (GMAB) pay dividends?

Genmab (GMAB) did not distribute dividends in the last year.

Q: Genmab (GMAB) is it worth it?

Currently, Genmab (GMAB) is priced at US$ 31,81, with a P/E of 16,72%, representing a deviation of 29,14% from its historical average P/E. In the last year, the stock showed a variation of 34.16% in its price and distributed US$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was 34,16%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How to buy stocks of Genmab (GMAB)?

Investing in stocks of Genmab (GMAB) can be done in two ways: by buying the stock no exterior. A stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much do 100 stocks of Genmab (GMAB) yield today?

The yield of Genmab (GMAB) was 14,71% in the last month, 34,16% in the last year and -16,57% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of US$ 0,00 in dividends, um Dividend Yield de 0,00%.If you wanted to buy 100 stocks of Genmab (GMAB) today, the total investment would be US$ 3.181,00, based on the current price of US$ 31,81.If past performance were to repeat, the return on your investment would be:In 1 year: US$ 4.267,63In 5 years: US$ 2.653,91In 10 years: 10.577,78It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Genmab A/S

Price

US$ 31,81

variation (12m)

34,16%

p/l

16,72

p/vp

3,91

DIVIDEND YIELD

0,00%

price GMAB

BVMF

GMAB

If you had invested

years ago

6 months

1 year

5 years

10 years

ago, today you would have

ago, today you would have:

*The figure considers the reinvestment of dividends.

Profitability of GMAB

1 month

3 months

1 year

2 years

5 years

10 years

profitability

1 month

14,71%

3 months

48,64%

1 year

34,16%

2 years

-2,72%

5 years

-16,57%

10 years

232,53%

real profitability

profitability minus inflation.

1 month

14,71%

3 months

48,09%

1 year

28,28%

2 years

-11,21%

5 years

-38,35%

10 years

99,09%

Indicators GMAB

check out the fundamentals of Genmab shares

P/E

16,72

Sector: 10,43 Industry: 50,85

P/SALES RATIO (PSR)

7,26

Sector: 1,07 Industry: 4,33

P/BV

3,91

Sector: 1,82 Industry: 19,40

DIVIDEND YIELD (DY)

0,00%

Sector: 0,39% Industry: 1,06%

ROA

19,19%

Sector: 1,38% Industry: 10,77%

ROE

23,39%

Sector: 5,76% Industry: 38,14%

ROIC

40,98%

Sector: -6,01% Industry: 22,15%

NET MARGIN

43,39%

Sector: 2,19% Industry: 14,65%

GROSS MARGIN

94,14%

Sector: 38,97% Industry: 45,78%

OPERATING MARGIN

36,91%

Sector: 5,64% Industry: 14,59%

P/EBITDA

14,17

Sector: 5,92 Industry: 29,30

P/EBIT

14,67

Sector: 7,02 Industry: 36,21

P/ASSET

3,21

Sector: 0,84 Industry: 3,42

BVPS

8,58

Sector: 10,21 Industry: 112,02

EPS

2,01

Sector: 0,85 Industry: 42,73

EQUITY / ASSETS

0,82

Sector: 0,31 Industry: 0,59

CAGR REVENUES 5 YEARS

10,93%

Sector: - Industry: -

CAGR PROFITS 5 YEARS

9,94%

Sector: - Industry: -

FAIR PRICE OF Genmab ASSETS ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Price

The Fair Price formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffet's mentor.

Current price

US$ 31,81

Fair Price

US$ 0,00

Upside Potencial de rentabilidade.

-38,07%

See Graham's ranking

Because it considers equity value in its calculation, the formula does not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

GMAB indicators history

DRAG THE FRAME TO SEE MORE DATA

Stocks comparator

DRAG THE FRAME TO SEE MORE DATA

	p/l	p/vp	ROE	dy	market value	net margin
AMZN	31,79	7,00	22,01%	0,00%	US$ 2,33 T	10,82%
MELI	50,85	19,40	38,14%	0,00%	US$ 110,81 B	8,52%
DIS	12,37	1,78	14,38%	0,89%	US$ 202,33 B	17,10%
VZ	9,27	1,77	19,06%	6,21%	US$ 184,46 B	14,39%
MCD	25,61	-77,86	-303,99%	2,35%	US$ 214,90 B	32,23%
WMT	38,31	8,41	21,94%	0,89%	US$ 814,31 B	3,08%
COST	50,24	13,94	27,74%	0,54%	US$ 406,43 B	2,92%
BABA	21,43	2,87	13,37%	1,06%	US$ 436,42 B	14,65%
T	11,19	1,58	14,13%	4,10%	US$ 195,08 B	13,99%
V	31,86	16,68	52,35%	0,67%	US$ 644,76 B	51,31%
NFLX	44,52	19,64	44,12%	0,00%	US$ 490,16 B	25,64%
SBUX	37,03	-12,69	-34,28%	2,84%	US$ 97,47 B	7,18%
HD	27,48	37,69	137,17%	2,26%	US$ 401,95 B	8,86%
TGT	9,73	2,59	26,65%	5,12%	US$ 39,98 B	3,96%
CMCSA	3,76	1,17	31,19%	4,14%	US$ 114,27 B	24,83%
LBRDP	1,40	0,36	25,89%	7,70%	US$ 3,27 B	100,00%
CMG	35,31	15,92	45,08%	0,00%	US$ 56,17 B	13,43%

comparison of GMAB with indexes

If you had invested (change) 2 years years ago, ago, today you would have

R$ 1.000,00 in PETR4 you would have R$ 2.294,60

R$ 1.000,00 in LEVE3 you would have R$ 5.240,60

*The value considers the reinvestment of dividends.

Dividend History GMAB

current DY: 0,00%

5-year average DY: 0,00%

no dividend paid in the period.

ABOUT THE COMPANY Genmab

Genmab A/S

Average user rating I10

4.0 (3 people)

Estados Unidos

27 years

Foundation: 1998

2019

Year of debut on the stock exchange - 6 years

781

Employees

The Company Genmab A/S (Estados Unidos), is listed on Nasdaq with a market value of $ 20,74 Billions, having a net worth of $ 5,30 Billions.

With a total of 781 employees, the company is listed in the sector of Services and categorized in industry of Commercial Services.

In the last 12 months the Company had a revenue of $ 2,86 Billions, which generated a profit in the amount of $ 1,24 Billion.

As for its main indicators, the Company has a P/E ratio of 16,72, a P/BV ratio of 3,91 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker GMAB.

Market value

US$ 20,74 Billions

Net worth

US$ 5,30 Billions

US$ 5.302.000.000,00

Assets

US$ 6,46 Billions

US$ 6.464.000.000,00

Total Number of Shares

618,00 Milhões

618.000.000

Average Daily Trading Volume

US$ 1,60 Million

US$ 1.602.770,34

Sector

Services

Industry

Commercial Services

GMAB

GMAB revenue and profits

GMAB results

DRAG THE FRAME TO SEE MORE DATA

GMAB cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

WSG - Wanda Sports Group

US$ - -0,00% (12M)

P/L

0,00

0,00%

ROE

-7,74%

P/VP

0,00

WMT - Walmart

US$ 101,84 28,67% (12M)

P/L

38,31

0,89%

ROE

21,94%

P/VP

8,41

AMZN - Amazon

US$ 216,37 15,37% (12M)

P/L

31,79

0,00%

ROE

22,01%

P/VP

7,00

COST - Costco Wholesale

US$ 930,01 5,15% (12M)

P/L

50,24

0,54%

ROE

27,74%

P/VP

13,94

JD - JD.com

US$ 31,85 --25,56% (12M)

P/L

9,25

2,80%

ROE

12,98%

P/VP

1,20

HD - Home Depot

US$ 375,75 --6,61% (12M)

P/L

27,48

2,26%

ROE

137,17%

P/VP

37,69

WBA - Walgreens Boots Alliance

US$ - -0,00% (12M)

P/L

-1,76

4,17%

ROE

-80,35%

P/VP

1,42

VZ - Verizon Communications

US$ 39,85 0,49% (12M)

P/L

9,27

6,21%

ROE

19,06%

P/VP

1,77

WSG - Wanda Sports Group

US$ - -0,00% (12 M)

P/L

0,00

0,00%

ROE

-7,74%

P/VP

0,00

WMT - Walmart

US$ 101,84 28,67% (12 M)

P/L

38,31

0,89%

ROE

21,94%

P/VP

8,41

AMZN - Amazon

US$ 216,37 15,37% (12 M)

P/L

31,79

0,00%

ROE

22,01%

P/VP

7,00

COST - Costco Wholesale

US$ 930,01 5,15% (12 M)

P/L

50,24

0,54%

ROE

27,74%

P/VP

13,94

JD - JD.com

US$ 31,85 --25,56% (12 M)

P/L

9,25

2,80%

ROE

12,98%

P/VP

1,20

HD - Home Depot

US$ 375,75 --6,61% (12 M)

P/L

27,48

2,26%

ROE

137,17%

P/VP

37,69

WBA - Walgreens Boots Alliance

US$ - -0,00% (12 M)

P/L

-1,76

4,17%

ROE

-80,35%

P/VP

1,42

VZ - Verizon Communications

US$ 39,85 0,49% (12 M)

P/L

9,27

6,21%

ROE

19,06%

P/VP

1,77

Frequently Asked Questions

What is the price of Genmab (GMAB) today?

The price of Genmab (GMAB) today is US$ 31,81, with a variation of 34.16% compared to the last year. The price of Genmab (GMAB) started the year trading around US$ 20,87 and today it is at US$ 31,81. Follow the real-time price chart, the historical price of Genmab (GMAB), and stock data from Ibovespa and international markets.

When does Genmab (GMAB) pay dividends?

Genmab (GMAB) did not distribute dividends in the last year.

Genmab (GMAB) is it worth it?

Currently, Genmab (GMAB) is priced at US$ 31,81, with a P/E of 16,72%, representing a deviation of 29,14% from its historical average P/E. In the last year, the stock showed a variation of 34.16% in its price and distributed US$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was 34,16%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How to buy stocks of Genmab (GMAB)?

Investing in stocks of Genmab (GMAB) can be done in two ways: by buying the stock no exterior. A stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much do 100 stocks of Genmab (GMAB) yield today?

The yield of Genmab (GMAB) was 14,71% in the last month, 34,16% in the last year and -16,57% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of US$ 0,00 in dividends, um Dividend Yield de 0,00%.

If you wanted to buy 100 stocks of Genmab (GMAB) today, the total investment would be US$ 3.181,00, based on the current price of US$ 31,81.

If past performance were to repeat, the return on your investment would be:

In 1 year: US$ 4.267,63
In 5 years: US$ 2.653,91
In 10 years: 10.577,78

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

GMAB

Genmab A/S

Price

variation (12m)

p/l

p/vp

DIVIDEND YIELD

Profitability of GMAB

check out the fundamentals of Genmab shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY / ASSETS

CAGR REVENUES 5 YEARS

CAGR PROFITS 5 YEARS

Graham's Fair Price

If you had invested (change) 2 years years ago, ago, today you would have

current DY: 0,00%

5-year average DY: 0,00%

ABOUT THE COMPANY Genmab

Genmab A/S

Estados Unidos

27 years

2019

781

PROFIT X PRICE GMAB

GMAB results

GMAB cash flow

evolution of assets - GMAB

GMAB balance sheet

WSG - Wanda Sports Group

WMT - Walmart

AMZN - Amazon

COST - Costco Wholesale

JD - JD.com

HD - Home Depot

WBA - Walgreens Boots Alliance

VZ - Verizon Communications

WSG - Wanda Sports Group

WMT - Walmart

AMZN - Amazon

COST - Costco Wholesale

JD - JD.com

HD - Home Depot

WBA - Walgreens Boots Alliance

VZ - Verizon Communications

Frequently Asked Questions